The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.

September 29 is World Heart Day. For the past six decades, Novartis has been working to advance heart health around the world.

Novartis COVID-19 Response Fund is providing urgently-needed support for healthcare workers and communities in over 50 projects around the world.

For over 40 years Novartis has been committed to understanding sickle cell disease and working towards treatment.

Learn how we are shifting from making the patient fit the treatment to making the treatment fit the patient.

A recent summit explored how technological advances could impact patient care.

The Novartis Foundation is launching a blood pressure management program in Vietnam as part of its larger effort to combat the rise of chronic diseases in urban areas of developing countries.

Understanding asthma: What are your misconceptions? This World Asthma Day find out more about asthma and challenge your misconceptions.

The Co-Creating Impact Summit happening on December 9th, 2020, will gather experts inside and outside of Novartis to continue our work of improving our impact on the society and the planet.

As a company, we stand up for greater inclusion of LGBTI people because when each of us feels included, we all benefit.